David Gordon
2019 - Aclaris Therapeutics
In 2019, David Gordon earned a total compensation of $1.4M as Former Chief Medical Officer at Aclaris Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $113,680 |
|---|---|
| Salary | $406,000 |
| Stock Awards | $843,592 |
| Other | $8,904 |
| Total | $1,372,176 |
Gordon received $843.6K in stock awards, accounting for 61% of the total pay in 2019.
Gordon also received $113.7K in non-equity incentive plan, $406K in salary and $8.9K in other compensation.
Rankings
In 2019, David Gordon's compensation ranked 7,778th out of 13,971 executives tracked by ExecPay. In other words, Gordon earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,778 out of 13,971 | 44th |
Division Manufacturing | 3,052 out of 5,701 | 47th |
Major group Chemicals And Allied Products | 1,151 out of 2,200 | 48th |
Industry group Drugs | 983 out of 1,886 | 48th |
Industry Pharmaceutical Preparations | 731 out of 1,398 | 48th |
Source: SEC filing on April 21, 2022.
Gordon's colleagues
We found three more compensation records of executives who worked with David Gordon at Aclaris Therapeutics in 2019.
News
Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
April 21, 2022
Coffee Holding Co CEO Andrew Gordon's 2021 pay slips 10% to $380K
February 28, 2022
Coffee Holding Co CEO Andrew Gordon's 2020 pay falls 66% to $421K
March 29, 2021
Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
April 23, 2020
Coffee Holding Co CEO Andrew Gordon's 2019 pay jumps 220% to $1.2M
February 28, 2020
Coffee Holding Co Secretary David Gordon's 2018 pay rises 2% to $389K
February 28, 2019